Clinical
RSSArticles
-
Postpartum Placement of Hormonal IUD Does Not Affect Breastfeeding Outcomes
Women can avoid unintended pregnancy and successfully breastfeed.
-
Tribulus: An RCT Supporting Its Use for Erectile Dysfunction
This double-blind, randomized, controlled trial in 180 men showed that a standardized extract of Tribulus terrestris improved erectile function after 12 weeks of treatment.
-
Acupuncture Decreases the Perception of Stress in a College Population
A verum acupuncture group led to a greater reduction in the perception of stress when compared to a sham acupuncture group.
-
Delafloxacin (Baxdela®)
Delafloxacin is a new broad-spectrum fluoroquinolone that was approved by the U.S. Food and Drug Administration in June 2017 for acute bacterial skin and skin structure infections.
-
Oily Fish Is Associated With Better Sleep
A study in Ecuador showed a strong positive correlation between dietary oily fish intake and sleep quality.
-
Caring for Providers: Mindfulness for Healthcare Practitioners
A review of studies regarding brief mindfulness interventions for healthcare providers found an association with improved measures of provider well-being and no evidence of behavioral changes.
-
Acupuncture and Neuromodulation in the Treatment of Migraine
Individuals suffering with migraine often use complementary and integrative therapies to treat migraine symptoms. Acupuncture has moderate evidence in reducing the frequency of migraine attacks, and neuromodulation is a promising treatment on the horizon for those suffering with migraine.
-
What Is the Ideal Target for Blood Pressure Control?
Patient-reported outcomes in a recent trial of subjects who received intensive treatment with a target systolic blood pressure of < 120 mmHg were similar to those who received standard care, supporting the recommendations of SPRINT.
-
Cerebrolysin Is Unproven as a Neuroprotectant for Acute Ischemic Stroke
The routine use of Cerebrolysin in acute stroke is not justified.
-
Idarucizumab for Reversal of the Anticoagulant Effects of Dabigatran
The administration of idarucizumab is effective and safe for the reversal of the direct thrombin inhibitor, dabigatran, and should be used in appropriate clinical situations.